Recombinant HTLV-1 E Protein

Product Overview

Human T-Cell Lymphotropic Virus Type I (HTLV-I) envelope Antigen, C-terminus of gp46 and most of p21E (amino acids 165-440) Recombinant. Immunoreactive with HTLV-I and HTLV-II positive sera with antibody response to HTLV envelope. Does not contain a fusion partner.

Target

HTLV-1

Nature

Recombinant

Tag/Conjugate

Unconjugated

Alternative Names

HTLV-I; Human T-cell lymphotropic virus type 1; human T-lymphotropic virus type 1; HTLV; HTLV-1 Envelope protein

Purity

> 95% pure (HPLC-C4 and 10% PAGE). Organic extraction> Ceramic Hydroxyapatite> S-300.

Format

Liquid

Buffer

10 mM Na-PO4, pH 6.0, containing 0.1% SDS, and 1 mM DTT.

Preservative

None

Storage

Upon receipt, store at -20°C. Avoid multiple freeze/thaw cycles.

Introduction

Human T-cell lymphotropic virus type 1 or human T-lymphotropic virus type 1 (HTLV-I), also called the adult T-cell lymphoma virus type 1, is a retrovirus of the human T-lymphotropic virus (HTLV) family that has been implicated in several kinds of diseases including very aggressive adult T-cell lymphoma (ATL), HTLV-I-associated myelopathy, uveitis, strongyloides stercoralis hyper-infection and some other diseases. However, only about 1–5% of infected persons are thought to develop cancer as a result of the infection with HTLV-I over their lifetimes.

Keywords

HTLV-I; Human T-cell lymphotropic virus type 1; human T-lymphotropic virus type 1; HTLV; HTLV-1 Envelope protein